Welcome to our dedicated page for RRE VENTURES ACQUISITION news (Ticker: RREVU), a resource for investors and traders seeking the latest updates and insights on RRE VENTURES ACQUISITION stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RRE VENTURES ACQUISITION's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RRE VENTURES ACQUISITION's position in the market.
RRE Ventures Acquisition Corp (NASDAQ:RREVU) closed its initial public offering of 25,000,000 units at $10.00 per unit, raising $250 million. Units began trading on April 30, 2026. Each unit contains one Class A ordinary share and one-third of a redeemable warrant.
Whole warrants carry an exercise price of $11.50 per share. Once separated, shares and warrants are expected to list as RREV and RREVW. Cohen and Company Capital Markets acted as lead representative; the SEC declared the registration effective on April 29, 2026.
RRE Ventures Acquisition Corp (NASDAQ:RREVU) priced an initial public offering of 25,000,000 units at $10.00 per unit, implying gross proceeds of $250 million. Trading of units is expected to begin on April 30, 2026, with closing expected on May 1, 2026, subject to customary conditions.
Each unit contains one Class A ordinary share and one-third of a redeemable warrant; whole warrants have an exercise price of $11.50. An underwriter option covers up to 3,750,000 additional units for 45 days to cover over-allotments. The SEC declared the registration statement effective on April 29, 2026.